Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
16.88 BRL | +5.17% | +4.91% | -0.06% |
Mar. 12 | Cosmetics group Natura's shares rise with higher margin, dividends even as loss widens | RE |
Mar. 12 | Transcript : Natura &Co Holding S.A., Q4 2023 Earnings Call, Mar 12, 2024 |
Summary
- According to Refinitiv, the company's ESG score for its industry is good.
Strengths
- With regards to fundamentals, the enterprise value to sales ratio is at 0.88 for the current period. Therefore, the company is undervalued.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- Analysts covering this company mostly recommend stock overweighting or purchase.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
- Over the past four months, analysts' average price target has been revised upwards significantly.
- Analyst opinion has improved significantly over the past four months.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
- With a 2024 P/E ratio at 29.68 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- The company is not the most generous with respect to shareholders' compensation.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- The sales outlook for the group was lowered in the last twelve months. This change in forecast points out a decline in activity as well as pessimistic analyses of the company.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last twelve months, the analysts covering the company have given a bearish overview of EPS estimates, resulting in frequent downward revisions.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-0.06% | 4.55B | B+ | ||
-3.33% | 249B | B- | ||
+10.09% | 18.86B | B+ | ||
0.00% | 17.37B | - | - | |
-1.32% | 10.65B | A- | ||
-7.73% | 10.26B | A- | ||
+3.86% | 6.72B | B+ | ||
+9.76% | 5.94B | B | ||
-16.98% | 3.83B | C- | ||
-6.25% | 3.48B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- NTCO3 Stock
- Ratings Natura &Co Holding S.A.